Immunogenicity and Diagnostic Assays in Early Vaccine Development and in Early/First-in-Human Vaccine Clinical Trials

In early vaccine clinical trials, assessments are conducted to evaluate the vaccine’s ability to stimulate an immune response, or “immunogenicity.” A vaccine-relevant immune response can consist of antigen-specific antibody production, peripheral T or B cell responses, and the generation of memory c